Cargando…
Circulating Nucleosomes and Nucleosome Modifications as Biomarkers in Cancer
Traditionally the stratification of many cancers involves combining tumour and clinicopathological features (e.g., patient age; tumour size, grade, receptor status and location) to inform treatment options and predict recurrence risk and survival. However, current biomarkers often require invasive e...
Autores principales: | McAnena, Peter, Brown, James A. L., Kerin, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295776/ https://www.ncbi.nlm.nih.gov/pubmed/28075351 http://dx.doi.org/10.3390/cancers9010005 |
Ejemplares similares
-
Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer
por: Bauden, Monika, et al.
Publicado: (2015) -
Inter-nucleosomal communication between histone modifications for nucleosome phasing
por: Chen, Weizhong, et al.
Publicado: (2018) -
Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer
por: McAnena, Peter, et al.
Publicado: (2019) -
Circulating cell-free nucleosomes as biomarkers for early detection of colorectal cancer
por: Rasmussen, Louise, et al.
Publicado: (2017) -
Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer
por: Rahier, Jean-François, et al.
Publicado: (2017)